Jill Davies

About Genome Medical

Genome Medical is making genetics care accessible and actionable for patients through seven-day-a-week access to genetic services. By partnering with health systems, molecular testing laboratories, and life sciences organizations, Genome Medical expands the practice and impact of genomic medicine to improve patient care. Genome Medical’s team of genetics providers supports its partners by providing expert clinical services including, pre-and post-test genetic counseling, genetic test review and authorization, genetic risk assessments, and genetic program advisory services. Its real-world data (RWD) offerings help accelerate partners’ therapy development and commercialization efforts. Genome Medical placed No. 663 on the 2023 Inc. 5000 list of fastest-growing private companies in America, received the MedTech Breakthrough 2023 “Genomics Innovation Award”, and has been recognized as the “Top 50 in Digital Health” by Fenwick & West and Goldman Sachs.